© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
Latebreakers: Once daily PAH drug OK'd
Ambrisentan (Letairis) in 5-and 10-mg tablets has been approved by the FDA for the treatment of pulmonary arterial hypertension (PAH).
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
Ambrisentan (Letairis) in 5-and 10-mg tablets has been approved by the FDA for the treatment of pulmonary arterial hypertension (PAH).